Belkyra – No More Double Chin

Love The Chin You're In Belykra | NEW Non-surgical Treatment Options for Double Chin

Belykra | Recent innovative advancements in medical aesthetics are providing physicians with new ways to enhance their patients’ appearance to achieve a more vibrant look.

Although in the past a double chin was mainly treated with invasive techniques like liposuction or a neck lift, now there are a variety of new options that are non-invasive, like double chin-reducing injections and fat-freezing technologies.

Visit The Best You to find out how you can get rid of your double chin once and for all.

Now is the time to learn more about how you can love the chin you’re in.

Belykra Get Rid of A Double Chin

No matter how often some people exercise or eat right, their double chin just won’t go away. However, with new advances in medical aesthetics, there are now a variety of ways your doctor can help treat this area so you can love the chin you’re in.

What Is a BELKYRA Treatment?

  • BELKYRA treatments involves use small needles to inject deoxycholic acid into fat cells.
  • BELKYRA breaks down fat cells in the area injected.
  • Sessions are generally 30 minutes.
  • Following treatment patients may have inflammation with swelling, redness, nodules, itching and numbness lasting typically 2- 4 weeks following the injection. Most rate these effects as mild.
  • Results typically take 4-6 weeks to fully evolve.

Can You Benefit From BELKYRA?

Double chins detract from an attractive and otherwise balanced face. BELKYRA is an effective alternative to liposuction and surgery.
BELYKRA is the only Health Canada approved injection treatment for moderate to severe submental fullness. The BELKYRATM injection is minimally invasive and can be done in short sessions

In Canadian and American clinical studies, 28%, 43% and 55% of BELKYRA-treated patients had at least a 1-grade improvement after 2, 3 and 4 treatments, respectively. What this means is improvement from moderate to mild fullness or from severe to moderate. 16% of patients had improvement of 2 or more grades